Study guide

13.4 Hirschsprung Disease & Biliary Atresia

Arab Board Pediatrics Part 1 Written Examination ABHS

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current ABHS Pediatrics Part 1 Exam Facts 1.2 How to Use This Guide & Part 1 Study Strategy

2 Neonatal Care I

2.1 Delivery-Room Management & Neonatal Resuscitation 2.2 Prematurity & Complications of Prematurity 2.3 Neonatal Jaundice & Hyperbilirubinemia

3 Neonatal Care II

3.1 Neonatal Sepsis & Infections 3.2 Neonatal Hypoglycemia & Metabolic Problems 3.3 Common Newborn Problems, Birth Injury & Screening

4 Infectious Diseases

4.1 Fever Without a Source & Sepsis Evaluation 4.2 Viral Exanthems & Common Childhood Infections 4.3 TORCH & Congenital Infections 4.4 Tuberculosis & Chronic/Unusual Pediatric Infections

5 Immunization

5.1 Routine Immunization Schedule & Vaccine Science 5.2 Contraindications, Adverse Events & Special Populations

6 Allergy & Immunology

6.1 Primary Immunodeficiency 6.2 Allergic Disease & Atopy

7 Growth & Development

7.1 Developmental Milestones & Red Flags 7.2 Growth Assessment & Failure to Thrive 7.3 Corrected Age & Preterm Follow-Up 7.4 Developmental & Behavioral Disorders

8 Nutrition

8.1 Breastfeeding & Infant Feeding 8.2 Weaning & Malnutrition 8.3 Micronutrient Deficiencies (Rickets, Iron Deficiency)

9 Pediatric Emergencies I

9.1 Pediatric Basic & Advanced Life Support 9.2 Anaphylaxis & Allergic Emergencies 9.3 Poisoning & Toxicology

10 Pediatric Emergencies II

10.1 Septic Shock & the Critically Ill Child 10.2 Upper Airway Emergencies (Epiglottitis, Foreign Body) 10.3 Non-Accidental Injury & Safeguarding

11 Cardiology

11.1 Cyanotic Congenital Heart Disease 11.2 Acyanotic Congenital Heart Disease & Heart Failure 11.3 Innocent Murmurs & Cardiac Evaluation 11.4 Rheumatic Fever & Acquired Heart Disease

12 Respiratory

12.1 Asthma 12.2 Bronchiolitis & Croup 12.3 Foreign Body Aspiration & Other Airway Disorders

13 Gastroenterology

13.1 Pyloric Stenosis & Vomiting Disorders 13.2 Intussusception & the Surgical Abdomen 13.3 Celiac Disease & Malabsorption 13.4 Hirschsprung Disease & Biliary Atresia

14 Nephrology & Genitourinary

14.1 Nephrotic Syndrome 14.2 Glomerulonephritis & Hematuria 14.3 UTI, Enuresis & Genitourinary Anomalies

15 Hematology & Oncology

15.1 Pediatric Anemias (Iron Deficiency, Thalassemia) 15.2 Sickle Cell Disease 15.3 Leukemia & Childhood Malignancies (incl. Wilms Tumor) 15.4 Bleeding & Platelet Disorders (ITP) & G6PD Deficiency

16 Endocrinology

16.1 Diabetes Mellitus & Diabetic Ketoacidosis 16.2 Thyroid & Adrenal Disorders 16.3 Growth Disorders & Puberty

17 Neurology

17.1 Febrile Seizures 17.2 Epilepsy Syndromes & Status Epilepticus 17.3 Bacterial Meningitis & CNS Infections 17.4 Neuromuscular Disorders & Headache

18 Genetics, Dysmorphology & Metabolism

18.1 Chromosomal Disorders & Dysmorphology 18.2 Inheritance Patterns, Consanguinity & Inborn Errors of Metabolism

19 Fluids, Electrolytes & Pharmacology

19.1 Maintenance Fluids & Dehydration 19.2 Electrolyte Disturbances 19.3 Pediatric Pharmacology & Prescribing/Dosing

20 Dermatology, ENT, Ophthalmology & Musculoskeletal

20.1 Common Pediatric Dermatology 20.2 ENT Disorders 20.3 Ophthalmology (Strabismus, Red Eye, Leukocoria) 20.4 Musculoskeletal & Rheumatologic Disorders

21 Adolescent Medicine & Ethics

21.1 Adolescent Health & Puberty 21.2 Ethics, Consent & Professionalism in Pediatrics

22 Final Review & Exam Strategy

22.1 High-Yield Numbers, Mnemonics & Cross-Topic Review 22.2 Exam-Day Strategy & Time Management

13.4 Hirschsprung Disease & Biliary Atresia

Key Takeaways Explain This Topic AI

Failure to pass meconium within 48 hours of birth is the single most testable clue for Hirschsprung disease, with the explosive "squirt sign" on rectal exam as a classic bedside finding.

Rectal suction biopsy is the gold-standard diagnostic test for Hirschsprung disease, showing absent ganglion cells, hypertrophied nerve trunks, and increased acetylcholinesterase-positive fibers.

Hirschsprung-associated enterocolitis is the feared complication, presenting with fever, distention, and explosive diarrhea that can progress rapidly to shock.

Any infant with jaundice persisting beyond 2 weeks of life must have a conjugated (direct) bilirubin measured to exclude biliary atresia before assuming physiologic or breast milk jaundice.

Kasai portoenterostomy outcomes are strongly time-dependent, with the best bile-flow success when performed before roughly 45-60 days of life.

Last updated: July 2026

Hirschsprung Disease

Hirschsprung disease (HD) is a congenital motility disorder caused by failure of neural crest cells to migrate completely into the distal hindgut during gestation, leaving a segment of bowel without ganglion cells in the submucosal (Meissner) and myenteric (Auerbach) plexuses. The aganglionic segment cannot relax, so it remains tonically contracted and functionally obstructs the passage of stool; the disease is always described by the extent of aganglionosis starting at the anus and extending proximally, most commonly confined to the rectosigmoid colon (short-segment disease, roughly 80% of cases). HD is more common in males, occurs in approximately 1 in 5,000 live births, and is associated with Down syndrome (trisomy 21) and other neurocristopathies such as multiple endocrine neoplasia type 2.

Presentation

The single most testable historical clue is failure to pass meconium within the first 48 hours of life in a term infant, a finding present in the large majority of HD cases and one that should always trigger consideration of HD rather than being dismissed. Affected neonates go on to develop progressive abdominal distention and bilious vomiting . On digital rectal exam, withdrawal of the examining finger is often followed by an explosive release of gas and stool , sometimes called the "squirt sign," as the obstruction is transiently decompressed — a classic bedside finding. Children with shorter aganglionic segments may present later in infancy or even childhood with chronic constipation, abdominal distention, and failure to thrive rather than a neonatal emergency, which broadens the differential with functional constipation; red flags favoring HD over functional constipation include onset from birth, failure to thrive, and an empty rectal vault despite a distended abdomen.

The most feared complication is Hirschsprung-associated enterocolitis (HAEC) , which can occur before or after surgical correction and presents with fever, marked abdominal distention, explosive or foul-smelling diarrhea, and rapid progression to sepsis and shock if untreated; management requires rectal irrigation, bowel decompression, IV fluids, and broad-spectrum antibiotics.

Diagnosis and Treatment

Rectal suction biopsy is the gold-standard diagnostic test: histology demonstrates the absence of ganglion cells in the submucosal plexus along with hypertrophied nerve trunks , and acetylcholinesterase histochemical staining shows increased, coarse acetylcholinesterase-positive fibers in the lamina propria, confirming the diagnosis when ganglion cells are absent. A contrast (barium) enema may show a transition zone — a caliber change between the narrow aganglionic distal segment and the dilated, normally innervated proximal bowel — but this zone can be subtle or absent in neonates because the proximal bowel has not yet had time to dilate, so a normal-appearing enema does not exclude HD and biopsy remains definitive.

Definitive treatment is surgical: a pull-through procedure , which resects the aganglionic segment and brings normally innervated, ganglionic bowel down to the anus, performed once the transition to normal ganglionic bowel is confirmed intraoperatively or by pathology, often after an initial period of decompression via rectal irrigations or, in some cases, a temporary colostomy.

Biliary Atresia and Neonatal Cholestasis

Biliary atresia (BA) is a progressive, fibro-obliterative process destroying the extrahepatic, and eventually intrahepatic, bile ducts, causing complete obstruction to bile flow. It is the single most common indication for pediatric liver transplantation and, if untreated, progresses to biliary cirrhosis and liver failure within the first two years of life.

The defining clinical feature is conjugated (direct) hyperbilirubinemia — jaundice that persists beyond the first 2 weeks of life (3 weeks in breastfed infants by some criteria) accompanied by pale, acholic stools and dark urine , reflecting failure of bilirubin to reach the gut. Hepatomegaly develops as obstruction progresses. The single highest-yield exam rule in this domain: any infant with jaundice persisting beyond 2 weeks of age must have a conjugated (direct) bilirubin fraction measured — jaundice should never be attributed to breast milk jaundice or physiologic jaundice without first excluding a conjugated hyperbilirubinemia, because early diagnosis of BA is time-critical.

Workup

Once conjugated hyperbilirubinemia is confirmed (generally direct bilirubin above 1 mg/dL if total bilirubin is below 5 mg/dL, or above 20% of total if higher), evaluation proceeds urgently:

Study Finding in biliary atresia

Abdominal ultrasound Absent or abnormal gallbladder; "triangular cord sign" (fibrotic cord at the porta hepatis)

Hepatobiliary scintigraphy (HIDA scan) , after phenobarbital priming No excretion of tracer into the bowel despite hepatic uptake

  • Liver biopsy Bile duct proliferation, portal fibrosis, bile plugs
  • Intraoperative cholangiogram Definitive confirmation of extrahepatic duct obstruction

The differential for conjugated hyperbilirubinemia in a neonate also includes choledochal cyst, neonatal (idiopathic) hepatitis, alpha-1 antitrypsin deficiency, TORCH infections, and metabolic or genetic cholestatic syndromes , all of which the workup above is designed to exclude.

Treatment

Definitive treatment is the Kasai portoenterostomy , in which the fibrotic extrahepatic biliary remnant is excised and a loop of jejunum is anastomosed directly to the porta hepatis to restore bile drainage from residual microscopic ductules. Outcomes are strongly time-dependent : success in achieving bile flow and clearing jaundice is substantially higher when the Kasai is performed before approximately 45-60 days of life , and outcomes decline with older age at surgery. This urgency is why the "jaundice beyond 2 weeks means check conjugated bilirubin" rule exists — every week of delay in recognizing BA is a week closer to a Kasai performed too late to succeed. Even after a successful Kasai, many children eventually develop progressive fibrosis and require liver transplantation , but a well-timed Kasai delays that need, often by years.